ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
StudyMifepristone Dose (mg)Delivery Regimen. Progesterone Dose (mg).NSurviving EmbryosSurviving Pregnancy Rate (%)Type of study
2
Delgado 2018aNRVaginal suppository. Dose not reported.341132%Observational case series.
3
Delgado 2018bNRVaginal oral capsules. Variety of doses, not reported.1566139%Observational case series.
4
Delgado 2018cNRIM: 200mg x 1 injection.502448%Observational case series.
5
Delgado 2018dNRIM: 200mg x 2-5 injections.362158%Observational case series.
6
Delgado 2012NRIM and/or oral: 200mg (1 or 2 per day), duration 9 weeks to 5 months.6467%Observational case series.
7
Garratt 2017NRVaginal: 400mg (2 per day) for 3 days, 400mg at night for 6 days, 200mg at night for 6 days.3267%Observational case series.
8
Delgado 2018eNROral: 2 x 200mg capsules (2 per day) for 3 days, 2 x 200mg capsules daily until end 1st trimester.312168%Observational case series.
9
Creinin 2020Oral: 200mgOral: 2 x 200mg capsules (2 per day) for 3 days, 2 x 200mg capsules daily until study exit visit.5480%Randomized controlled trial.
10
Turner 2023NROral: 4 x 100mg capsules (2 x day) for 3 days, 4 x 100mg capsules at night for 16 days.6583%Single-arm clinical trial.
11
Delgado 2018fNRIM: 200mg x 11+ injections.191789%Observational case series.
12
Delgado 2018gNRIM: 200mg x 9-10 injections.10990%Observational case series.
13
Delgado 2018hNRIM: 200mg x 6-8 injections.99100%Observational case series.
14
NR=Not reportedIM=Intramuscular
15
10-Jan-2024
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100